Disclosure 0001437749-26-032864-1

SEC FORM 4

—

Moleculin Biotech, Inc. (MBRX)

Acquisition (code M) of 130,000 shares; price not stated (see filing).

Reporting Person Foster Jonathan P. · Officer Title Chief Financial Officer · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001437749-26-032864 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Moleculin Biotech, Inc. (MBRX)." Disclosed 2026-10-16. https://desqlong.com/cards/0001437749-26-032864-1 (retrieved 2026-10-17).